(Q82645156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

M Stern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

L Bühlmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A S Buser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Cantoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Gerull

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Tichelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Gratwohl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

29 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1357-1362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21113185%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.306

17 January 2020

exact match

0 references

cites work

Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzuma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Enumeration of peripheral lymphocyte subsets using 6 vs. 4 color staining: a clinical evaluation of a new flowcytometer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021

Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.306

7 January 2021